Roundtable Discussion – Redefining the Standard for Atrial Fibrillation Treatment
This roundtable event features a former atrial fibrillation (AF) patient and a group of leading electrophysiologists in a discussion moderated by Prof. Richard Schilling, British Heart Rhythm Society President.
The topics addressed included the following:
- AF patient expectations for treatment
- Risks and benefits associated with AF ablation compared to AAD therapy
- The role of AF management guidelines in improving the standard of care delivered to patients
- Measuring and tracking outcomes that matter to patients
- The ideal AF patient pathway
Faculty: Prof Richard Schilling, Prof Helmut Pürerfellner, Prof Carina Blomström-Lundqvist, and AF patient Alex White
The objective of this roundtable is to discuss:
- Who should be referred for an AF ablation, what to expect, and what outcomes tend to matter most to AF patients
- The benefits of AF ablation vs. AAD therapy
- The latest evidence influencing AF management guidelines
- The ideal AF patient pathway now and going forward
- AF progression and the benefits associated with early detection and treatment
The presentation recordings primarily target general practitioners, AF patients, hospital administrators, and healthcare insurance providers. General cardiologists, allied health professionals, and electrophysiologists may also benefit from this content.